SEC 13F · Q3 2026

Health Care Stocks Held by Hedge Funds

All health care-sector stocks held by tracked institutional funds per the latest SEC 13F filings, sorted by number of fund holders.

CYH Community Health Systems
1.61 -13.44%
Health Care 1M -42.9%
122Funds Holding
$131.28MInstitutional value
-67vs last quarter
D. E. Shaw & Co AQR Capital Management Millennium Management Marshall Wace +118 View holders →
INBX Inhibrx Biosciences
74.33 +7.63%
Health Care 1M -24.3%
122Funds Holding
$887.83MInstitutional value
-51vs last quarter
Viking Global Investors Marshall Wace Millennium Management AQR Capital Management +118 View holders →
RCKT Rocket Pharmaceuticals
2.11 +0.00%
Health Care 1M -4.1%
122Funds Holding
$162.48MInstitutional value
-68vs last quarter
Millennium Management Maverick Capital Marshall Wace AQR Capital Management +118 View holders →
VMD Viemed Healthcare
8.61 -1.94%
Health Care 1M -11.7%
122Funds Holding
$172.63MInstitutional value
-52vs last quarter
Arrowstreet Capital Renaissance Technologies AQR Capital Management Millennium Management +118 View holders →
RAPP Rapport Therapeutics
23.59 +0.81%
Health Care 1M -5.9%
121Funds Holding
$852.20MInstitutional value
-47vs last quarter
D. E. Shaw & Co AQR Capital Management Millennium Management +118 View holders →
ACRS Aclaris Therapeutics
3.50 +0.00%
Health Care 1M -8.1%
120Funds Holding
$404.79MInstitutional value
-37vs last quarter
Marshall Wace Renaissance Technologies AQR Capital Management Millennium Management +116 View holders →
ARCT Arcturus Therapeutics Holdings
7.60 -5.47%
Health Care 1M -31.3%
120Funds Holding
$285.40MInstitutional value
-22vs last quarter
ARK Invest D. E. Shaw & Co AQR Capital Management Millennium Management +116 View holders →
SIGA Siga Technologies
2.65 -5.36%
Health Care 1M -15.1%
120Funds Holding
$83.34MInstitutional value
-50vs last quarter
Arrowstreet Capital Renaissance Technologies AQR Capital Management Millennium Management +116 View holders →
ELDN Eledon Pharmaceuticals
1.90 -6.40%
Health Care 1M -15.9%
119Funds Holding
$62.89MInstitutional value
-50vs last quarter
Millennium Management Renaissance Technologies AQR Capital Management +116 View holders →
BCAX Bicara Therapeutics
9.12 -2.77%
Health Care 1M -49.1%
118Funds Holding
$606.31MInstitutional value
-66vs last quarter
Millennium Management D. E. Shaw & Co Marshall Wace AQR Capital Management +114 View holders →
GPCR Structure Therapeutics
17.12 -1.38%
Health Care 1M -22.2%
118Funds Holding
$1.01BInstitutional value
-85vs last quarter
D. E. Shaw & Co Marshall Wace Millennium Management +115 View holders →
ABCL Abcellera Biologics
10.47 -4.99%
Health Care 1M -14.5%
117Funds Holding
$978.75MInstitutional value
-39vs last quarter
Marshall Wace Millennium Management Arrowstreet Capital Renaissance Technologies +113 View holders →
NUS Nu Skin Enterprises
3.77 -2.58%
Health Care 1M -20.8%
117Funds Holding
$112.90MInstitutional value
-53vs last quarter
Renaissance Technologies AQR Capital Management D. E. Shaw & Co Millennium Management +113 View holders →
SVRA Savara
5.21 +10.38%
Health Care 1M +11.6%
117Funds Holding
$446.67MInstitutional value
-71vs last quarter
Marshall Wace D. E. Shaw & Co AQR Capital Management +114 View holders →
FDMT 4D Molecular
10.72 +2.49%
Health Care 1M -15.1%
116Funds Holding
$285.55MInstitutional value
-51vs last quarter
Renaissance Technologies Millennium Management AQR Capital Management D. E. Shaw & Co +112 View holders →
LXRX Lexicon Pharmaceuticals
1.67 -2.91%
Health Care 1M +7.1%
116Funds Holding
$647.07MInstitutional value
-41vs last quarter
Millennium Management AQR Capital Management D. E. Shaw & Co +113 View holders →
PHAT Phathom Pharmaceuticals
5.08 -4.15%
Health Care 1M -27.7%
116Funds Holding
$306.82MInstitutional value
-55vs last quarter
Millennium Management D. E. Shaw & Co AQR Capital Management Renaissance Technologies +112 View holders →
SEPN Septerna
39.20 -0.63%
Health Care 1M -3.8%
116Funds Holding
$523.72MInstitutional value
-51vs last quarter
D. E. Shaw & Co Arrowstreet Capital Millennium Management AQR Capital Management +112 View holders →
OCGN Ocugen
0.73 -0.87%
Health Care 1M -10.1%
115Funds Holding
$103.48MInstitutional value
-41vs last quarter
Marshall Wace Millennium Management AQR Capital Management +112 View holders →
ZBIO Zenas Biopharma
25.04 -5.22%
Health Care 1M -10.8%
114Funds Holding
$1.21BInstitutional value
-48vs last quarter
Marshall Wace AQR Capital Management Millennium Management +111 View holders →
CADL Candel Therapeutics
5.13 -3.57%
Health Care 1M -38.7%
113Funds Holding
$358.72MInstitutional value
-33vs last quarter
Millennium Management D. E. Shaw & Co AQR Capital Management Marshall Wace +109 View holders →
MLTX Moonlake Immunotherapeutics
11.03 +2.22%
Health Care 1M +3.6%
113Funds Holding
$247.65MInstitutional value
-66vs last quarter
D. E. Shaw & Co Renaissance Technologies Millennium Management Arrowstreet Capital +109 View holders →
AVIR Atea Pharmaceuticals
3.93 -1.50%
Health Care 1M -3.7%
112Funds Holding
$263.34MInstitutional value
-20vs last quarter
Renaissance Technologies AQR Capital Management D. E. Shaw & Co Arrowstreet Capital +108 View holders →
CRBU Caribou Biosciences
0.31 -4.78%
Health Care 1M -42.9%
112Funds Holding
$52.88MInstitutional value
-29vs last quarter
Renaissance Technologies AQR Capital Management Maverick Capital Marshall Wace +108 View holders →
VSTM Verastem
6.86 -0.15%
Health Care 1M -25.5%
112Funds Holding
$343.97MInstitutional value
-55vs last quarter
AQR Capital Management Millennium Management Renaissance Technologies +109 View holders →
BIOA BioAge Labs
4.71 -1.26%
Health Care 1M -14.5%
111Funds Holding
$131.27MInstitutional value
-46vs last quarter
D. E. Shaw & Co Millennium Management Renaissance Technologies AQR Capital Management +107 View holders →
CAPR Capricor Therapeutics
7.53 -6.23%
Health Care 1M +28.1%
111Funds Holding
$201.60MInstitutional value
-73vs last quarter
Millennium Management D. E. Shaw & Co +109 View holders →
LCTX Lineage Cell Therapeutics in
0.82 -2.21%
Health Care 1M -13.7%
111Funds Holding
$55.18MInstitutional value
-25vs last quarter
Millennium Management Renaissance Technologies Marshall Wace AQR Capital Management +107 View holders →
STVN Stevanato Group
15.93 +3.71%
Health Care 1M -15.4%
109Funds Holding
$889.63MInstitutional value
-22vs last quarter
D. E. Shaw & Co Marshall Wace +107 View holders →
BBNX Beta Bionics
13.32 -7.05%
Health Care 1M -27.6%
107Funds Holding
$767.69MInstitutional value
-38vs last quarter
D. E. Shaw & Co AQR Capital Management Renaissance Technologies Millennium Management +103 View holders →
CABA Cabaletta Bio
1.01 -4.27%
Health Care 1M -34.4%
106Funds Holding
$133.89MInstitutional value
-46vs last quarter
Marshall Wace Millennium Management Renaissance Technologies AQR Capital Management +102 View holders →
JBIO Jade Biosciences
15.06 -2.78%
Health Care 1M -0.5%
106Funds Holding
$540.67MInstitutional value
-56vs last quarter
Marshall Wace Millennium Management D. E. Shaw & Co Renaissance Technologies +102 View holders →
CHRS Coherus Oncology
0.39 -5.56%
Health Care 1M -62.0%
105Funds Holding
$66.13MInstitutional value
-48vs last quarter
Renaissance Technologies AQR Capital Management Millennium Management +102 View holders →
FATE Fate Therapeutics
1.01 -3.81%
Health Care 1M -51.2%
105Funds Holding
$95.51MInstitutional value
-57vs last quarter
Renaissance Technologies Arrowstreet Capital Millennium Management Marshall Wace +101 View holders →
TYRA Tyra Biosciences
19.73 +0.61%
Health Care 1M -4.2%
105Funds Holding
$688.95MInstitutional value
-70vs last quarter
AQR Capital Management Millennium Management D. E. Shaw & Co Marshall Wace +101 View holders →
VOR Vor Biopharma
18.52 +3.87%
Health Care 1M -2.2%
105Funds Holding
$459.75MInstitutional value
-3vs last quarter
Millennium Management Marshall Wace D. E. Shaw & Co AQR Capital Management +101 View holders →
HUMA Humacyte
0.54 +8.50%
Health Care 1M +32.0%
104Funds Holding
$23.31MInstitutional value
-71vs last quarter
Marshall Wace AQR Capital Management Renaissance Technologies +101 View holders →
OSUR Orasure Technologies
3.61 +0.56%
Health Care 1M -6.5%
104Funds Holding
$163.73MInstitutional value
-54vs last quarter
Renaissance Technologies D. E. Shaw & Co AQR Capital Management Arrowstreet Capital +100 View holders →
PLSE Pulse Biosciences
44.41 -3.10%
Health Care 1M -13.4%
104Funds Holding
$504.56MInstitutional value
-11vs last quarter
D. E. Shaw & Co Millennium Management Marshall Wace AQR Capital Management +100 View holders →
SLDB Solid Biosciences
6.44 +1.42%
Health Care 1M +0.5%
104Funds Holding
$352.32MInstitutional value
-60vs last quarter
Millennium Management AQR Capital Management D. E. Shaw & Co Marshall Wace +100 View holders →
AURA Aura Biosciences
6.98 -2.24%
Health Care 1M +8.0%
103Funds Holding
$202.13MInstitutional value
-54vs last quarter
D. E. Shaw & Co Renaissance Technologies AQR Capital Management +100 View holders →
DCTH Delcath Systems
19.24 -2.34%
Health Care 1M +30.9%
103Funds Holding
$209.22MInstitutional value
-29vs last quarter
Millennium Management Marshall Wace Arrowstreet Capital AQR Capital Management +99 View holders →
LRMR Larimar Therapeutics
3.22 -0.16%
Health Care 1M +33.1%
103Funds Holding
$127.96MInstitutional value
-64vs last quarter
AQR Capital Management Marshall Wace Millennium Management D. E. Shaw & Co +99 View holders →
MMED Minimed Group
16.26 -4.30%
Health Care 1M -8.7%
103Funds Holding
$723.25MInstitutional value
-2vs last quarter
Millennium Management Marshall Wace D. E. Shaw & Co Renaissance Technologies +99 View holders →
FULC Fulcrum Therapeutics
3.71 -0.27%
Health Care 1M +0.3%
102Funds Holding
$166.57MInstitutional value
-61vs last quarter
D. E. Shaw & Co Renaissance Technologies Marshall Wace AQR Capital Management +98 View holders →
IMRX Immuneering
3.45 -1.43%
Health Care 1M -7.8%
102Funds Holding
$133.65MInstitutional value
-17vs last quarter
Marshall Wace D. E. Shaw & Co Millennium Management AQR Capital Management +98 View holders →
INGN Inogen
5.42 -2.69%
Health Care 1M -18.7%
102Funds Holding
$63.35MInstitutional value
-30vs last quarter
Arrowstreet Capital AQR Capital Management Renaissance Technologies Marshall Wace +98 View holders →
LXEO Lexeo Therapeutics
2.95 +0.00%
Health Care 1M -1.7%
102Funds Holding
$144.98MInstitutional value
-49vs last quarter
Millennium Management Renaissance Technologies Marshall Wace AQR Capital Management +98 View holders →
ANIK Anika Therapeutics
13.28 -2.50%
Health Care 1M -35.5%
101Funds Holding
$155.97MInstitutional value
-37vs last quarter
Renaissance Technologies AQR Capital Management Arrowstreet Capital D. E. Shaw & Co +97 View holders →
AVBP Arrivent Biopharma
11.26 +3.30%
Health Care 1M -41.1%
101Funds Holding
$581.42MInstitutional value
-64vs last quarter
D. E. Shaw & Co Millennium Management AQR Capital Management +98 View holders →

1036 stocks in Health Care · prices as of 2026-11-19